Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FSDRE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,252
Award facts
- Contract value 100% obligated
- $15,251.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,251.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitive award, which involved no set-aside designation, represents a firm fixed-price delivery order executed under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The product will be delivered to AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania. Zepbound (tirzepatide) is a pharmaceutical product used in diabetes and weight management treatment, aligning with AmerisourceBergen's extensive portfolio of specialty medications supplied to federal healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a substantial relationship with DLA as a primary vendor for medical supply chain operations. The company's $999.999 billion IDC with DLA Troop Support Medical through December 2026 serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications, vaccines, and medical devices to military healthcare programs worldwide. This delivery order reflects the company's continued role in supporting Defense Health Agency operations and other federal healthcare systems through competitively awarded transactions demonstrating pricing flexibility across transactions ranging from minimal to substantial values.
Quick answers
Who was awarded contract SPE2DB25FSDRE?
SPE2DB25FSDRE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FSDRE worth?
The government has obligated $15,252 on SPE2DB25FSDRE.
Is contract SPE2DB25FSDRE an order under another contract?
Yes. SPE2DB25FSDRE is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSDRE competed?
The extent of competition for SPE2DB25FSDRE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award